Indications and use of abdominal angiography in trauma

Gw, Kauffmann; Wenz, W; Strecker, E P; Kotoulas, K

doi:10.1007/bf02552015

Cited by 2 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Coils are also an option, particularly in the "back door embolization" technique, during which an extratumoral branch arising from a tumoral feeder is occluded for protective purposes to avoid ischemic complications. However, coils are not recommended as the sole embolic agent in tumor embolization because they cannot provide distal vessel embolization, which is necessary for hypervascular tumors with multiple collaterals [28]. The different embolic agents available do not provide the same effectiveness in terms of devascularization but they are complementary because of their different properties.…”

Section: Discussionmentioning

confidence: 99%

Preoperative Arterial Embolization of Musculoskeletal Tumors: A Tertiary Center Experience

Kedra

Dohan

Biau

et al. 2023

Cancers

View full text Add to dashboard Cite

The purpose of this study was to report the effectiveness of preoperative transcatheter arterial embolization (TAE) of musculoskeletal tumors in terms of blood loss and functional outcomes. Patients who underwent preoperative TAE of hypervascular musculoskeletal tumors between January 2018 and December 2021 were retrospectively included. The patients’ characteristics, TAE procedure details, degree of post-TAE devascularization, surgical outcomes in terms of red blood cell transfusion and functional results were collected. The degree of devascularization was compared between patients who had peri-operative transfusion and those who did not. Thirty-one patients were included. The 31 TAE procedures led to complete (58%) or near-complete (42%) tumor devascularization. Twenty-two patients (71%) had no blood transfusion during surgery. Nine patients (29%) had a blood transfusion, with a median number of red blood cell packs of three (q1, 2; q3, 4; range: 1–4). Eight patients (27%) had complete improvement of the initial musculoskeletal symptoms at the end of the follow-up, 15 (50%) had partially satisfying improvement, 4 (13%) had partially unsatisfying improvement and 3 (10%) had no improvement. Our study suggests that preoperative TAE of hypervascular musculoskeletal tumors allowed for bloodless surgery in 71% of patients and minimal transfusion needs for the remaining 29%.

show abstract

Section: Discussionmentioning

confidence: 99%